Present benchmarks on dental supply spending, prices, formulary compliance, and DSO growth using procurement data from Dentira’s platform.
Approach:
Dataset: Dentira says the Fall 2026 Index draws on purchasing, formulary, budget, and invoice activity from 267 DSOs representing 15,000 U.S. locations.
Reporting: Benchmarks are reported by DSO size and supply category; Dentira says results are aggregated at segment and category levels to protect confidentiality.
Key Findings:
DSOs with at least 101 locations spent an average of 4.1% of collections on supplies, compared with 7.4% for DSOs with 10 or fewer locations.
Prices rose in all 10 examined supply categories from 2021 to 2025. Labels and signs increased 20.1%, and disposables increased 15.8%.
About half of products ordered in the dataset were outside DSOs’ formularies; enterprise DSOs had a 45% off-formulary ordering rate.
Reported growth rates were 32% for small and midsize DSOs, 26% for mid-market DSOs, and 16% for strategic DSOs. Enterprise DSO growth rose from 18% to 26%.
The South Atlantic accounted for nearly one-third of acquisitions among DSOs on Dentira’s platform over three years; Florida, Texas, and California had the highest activity among states.
Implants and bone regeneration materials were among the four highest-spending categories in every DSO segment.
Dentira reports that platform customers reduced supply spending by an average of 1.1 percentage points of collections in their first year, from 8% to 6.9%.
Interpretation:
The Index provides Dentira-derived benchmarks for supply spending and procurement patterns across DSO sizes and categories.
Limitations:
The findings are based on procurement activity recorded through Dentira’s platform and may not represent DSOs outside its dataset.
The context does not provide detailed methods, sample characteristics beyond the reported DSO and location counts, or statistical uncertainty.
The reported first-year spending reduction among platform customers is company-reported; the context does not describe a comparison group or causal analysis.
Conclusion:
The Index includes Dentira’s Dental Spend Maturity Model and a 90-day procurement plan. Dentira says the Spring 2027 edition is expected to add category-level formulary analysis.
Findings highlight opportunities for dental professionals to improve patient education, address barriers to oral hygiene, and encourage sustainable preventive care habits.